Sponsor Pipeline

Atisama Therapeutics Clinical Trial Pipeline

Data updated daily from ClinicalTrials.gov — last refresh 2026-08-16
1
Active Trials
1
Recruiting
1
Disease Areas
4
Changes, 30 Days
What Changed in the Last 30 Days
DetectedTrialChange
2026-08-13 NCT07285122
Inhaled RB042 in Healthy Adult Volunteers, Healthy Adult Smokers and Patients With…		 Enrollment increased: 90 -> 105 participants
2026-08-13 NCT07285122
Inhaled RB042 in Healthy Adult Volunteers, Healthy Adult Smokers and Patients With…		 Trial arms changed: 8 -> 10
2026-08-13 NCT07285122
Inhaled RB042 in Healthy Adult Volunteers, Healthy Adult Smokers and Patients With…		 date change Primary completion pushed: 2027-02 -> 2027-10
2026-08-13 NCT07285122
Inhaled RB042 in Healthy Adult Volunteers, Healthy Adult Smokers and Patients With…		 date change Completion pushed: 2027-02 -> 2027-10
Active Trials by Phase
Phase 1
1
Active Trials
NCT IDTitleConditionStatus
Phase 1
NCT07285122 Inhaled RB042 in Healthy Adult Volunteers, Healthy Adult Smokers and Patients With… Healthy Recruiting
Disease Areas
COPD (1)
Get alerts when Atisama Therapeutics's trials change
Status changes, date slips, and new filings — detected daily, delivered to your inbox.
Start monitoring free